Statewide membership of translational cancer research centres (TCRCs)

Why this indicator is important

The NSW government, through the Cancer Institute NSW, established the Translational Cancer Research Centre (TCRC) Program in 2011. Its goal was to facilitate collaborations between clinicians and researchers and support rapid translation of research findings from bench to bedside. 

The program invested in seven TCRCs with a successful result of: 

  • new and strengthened collaborations between researchers and clinicians
  • a bridged gap between research and care, and
  • increased capacity for system-wide practice change. 

Building on the success of this program, from 1 July 2021, the Institute modified its translational cancer research funding model to increase its investment in the established Translational Program Grant. 
The improved funding model aligns translational cancer research capacity building with the National Health and Medical Research Council’s three recognised NSW Health Research and Translation Centres: Maridulu Budyari Gumal (SPHERE)NSW Regional Health Partners and Sydney Health Partners.

This model brings together researchers, healthcare providers, education and training to strengthen cancer research capacity. Ultimately, this will drive improvements in cancer care and outcomes for people living with cancer across the state.

About this indicator

The Cancer Institute NSW funded seven translational cancer research centres, bringing together over 1200 members (clinicians and researchers) across more than 95 institutions.

1200 memberships of of statewide translational cancer research centres recorded in 2019.

Source: TCRC progress reports database